These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 39239735
21. Use of Monoclonal Antibodies in the Sensitive Detection and Neutralization of Botulinum Neurotoxin Serotype B. Cheng LW, Henderson TD, Lam TI, Stanker LH. Toxins (Basel); 2015 Nov 27; 7(12):5068-78. PubMed ID: 26633496 [Abstract] [Full Text] [Related]
22. Neutralizing Concentrations of Anti-Botulinum Toxin Antibodies Positively Correlate with Mouse Neutralization Assay Results in a Guinea Pig Model. Tomic MT, Farr-Jones S, Syar ES, Niemuth N, Kobs D, Hackett MJ, Espinoza Y, Martinez Z, Pham K, Snow DM, Marks JD, Cobb RR. Toxins (Basel); 2021 Sep 21; 13(9):. PubMed ID: 34564675 [Abstract] [Full Text] [Related]
23. A label-free biosensor assay for botulinum neurotoxin B in food and human serum. Ferracci G, Marconi S, Mazuet C, Jover E, Blanchard MP, Seagar M, Popoff M, Lévêque C. Anal Biochem; 2011 Mar 15; 410(2):281-8. PubMed ID: 21134347 [Abstract] [Full Text] [Related]
24. A Four-Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotypes C and D. Garcia-Rodriguez C, Yan S, Geren IN, Knopp KA, Dong J, Sun Z, Lou J, Conrad F, Wen WH, Farr-Jones S, Smith TJ, Brown JL, Skerry JC, Smith LA, Marks JD. Toxins (Basel); 2021 Sep 10; 13(9):. PubMed ID: 34564645 [Abstract] [Full Text] [Related]
25. Progress in cell based assays for botulinum neurotoxin detection. Pellett S. Curr Top Microbiol Immunol; 2013 Sep 10; 364():257-85. PubMed ID: 23239357 [Abstract] [Full Text] [Related]
26. Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells. Lam KH, Perry K, Shoemaker CB, Jin R. Toxins (Basel); 2020 Sep 27; 12(10):. PubMed ID: 32992561 [Abstract] [Full Text] [Related]
27. Isolation and characterization of a neutralizing antibody specific to internalization domain of Clostridium botulinum neurotoxin type B. Yang GH, Kim KS, Kim HW, Jeong ST, Huh GH, Kim JC, Jung HH. Toxicon; 2004 Jul 27; 44(1):19-25. PubMed ID: 15225558 [Abstract] [Full Text] [Related]
28. A natural human IgM antibody that neutralizes botulinum neurotoxin in vivo. Adekar SP, Al-Saleem FH, Elias MD, Rybinski KA, Simpson LL, Dessain SK. Hybridoma (Larchmt); 2008 Apr 27; 27(2):65-9. PubMed ID: 18642670 [Abstract] [Full Text] [Related]
29. A protein chip membrane-capture assay for botulinum neurotoxin activity. Marconi S, Ferracci G, Berthomieu M, Kozaki S, Miquelis R, Boucraut J, Seagar M, Lévêque C. Toxicol Appl Pharmacol; 2008 Dec 15; 233(3):439-46. PubMed ID: 18845174 [Abstract] [Full Text] [Related]
30. Production and characterization of a neutralizing antibody against botulinum neurotoxin A. Xiong X, Lv S, Fu C, Li L, Sun Z, Han X, Zhang W. J Immunol Methods; 2020 Dec 15; 487():112871. PubMed ID: 33007319 [Abstract] [Full Text] [Related]
31. The receptor binding domain of botulinum neurotoxin serotype A (BoNT/A) inhibits BoNT/A and BoNT/E intoxications in vivo. Ben David A, Diamant E, Barnea A, Rosen O, Torgeman A, Zichel R. Clin Vaccine Immunol; 2013 Aug 15; 20(8):1266-73. PubMed ID: 23761665 [Abstract] [Full Text] [Related]
32. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain. Pellett S, Tepp WH, Bradshaw M, Kalb SR, Dykes JK, Lin G, Nawrocki EM, Pier CL, Barr JR, Maslanka SE, Johnson EA. mSphere; 2016 Aug 15; 1(1):. PubMed ID: 27303710 [Abstract] [Full Text] [Related]
33. Botulinum neurotoxins and botulism: a novel therapeutic approach. Thanongsaksrikul J, Chaicumpa W. Toxins (Basel); 2011 May 15; 3(5):469-88. PubMed ID: 22069720 [Abstract] [Full Text] [Related]
34. A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes. Garcia-Rodriguez C, Razai A, Geren IN, Lou J, Conrad F, Wen WH, Farr-Jones S, Smith TJ, Brown JL, Skerry JC, Smith LA, Marks JD. Toxins (Basel); 2018 Mar 01; 10(3):. PubMed ID: 29494481 [Abstract] [Full Text] [Related]
35. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Garcia-Rodriguez C, Geren IN, Lou J, Conrad F, Forsyth C, Wen W, Chakraborti S, Zao H, Manzanarez G, Smith TJ, Brown J, Tepp WH, Liu N, Wijesuriya S, Tomic MT, Johnson EA, Smith LA, Marks JD. Protein Eng Des Sel; 2011 Mar 01; 24(3):321-31. PubMed ID: 21149386 [Abstract] [Full Text] [Related]
36. Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain. Avril A, Miethe S, Popoff MR, Mazuet C, Chahboun S, Rasetti-Escargueil C, Sesardic D, Thullier P, Hust M, Pelat T. BMC Biotechnol; 2015 Sep 17; 15():86. PubMed ID: 26382731 [Abstract] [Full Text] [Related]
37. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes. Baldwin MR, Barbieri JT. Biochemistry; 2007 Mar 20; 46(11):3200-10. PubMed ID: 17311420 [Abstract] [Full Text] [Related]
39. Expression, purification and development of neutralizing antibodies from synthetic BoNT/B LC and its application in detection of botulinum toxin serotype B. Ponmariappan S, Jain S, Sijoria R, Tomar A, Kumar O. Protein Pept Lett; 2012 Mar 20; 19(3):288-98. PubMed ID: 21933129 [Abstract] [Full Text] [Related]